Psychedelics company
Silo Wellness Inc. (CSE:SILO) (FRA: 3K70) will expand its portfolio of psilocybin and ketamine product and retreat offerings to include 5-MeO-DMT, Benzinga has learned exclusively ahead of an official announcement.
The addition of O-methyl-bufotenin to the company’s offering will be enabled through a partnership with
Kaivalya Kollectiv, a Los Angeles-based wellness company that conducts psychedelic-integrated spiritual coaching and facilitated retreats in Mexico, Jamaica and Costa Rica. Through the agreement, Silo Wellness will integrate the 5-MeO-DMT experience into two new Jamaican retreats featuring yoga, meditation, breath work and spiritual coaching, as well as unique culinary and cultural experiences.